1van de Kerkhof PC, Vissers WH. The topical treatment of psoriasis. Skin Pharmacol Appl Skin Physiol, 2003, 16: 69-83.
2Liem WH, McCullough JL, Weinstein GD.Effectiveness of topical therapy for psoriasis: results of a national survey. Cutis.1995, 55: 306-310.
3Gollnick H, Menter A. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol, 1999, 140 Suppl 54: 18-23.
4Grattan CE, Christopher AP, Robinson M,et al. Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis. Br J Dermatol, 1988, 119: 623-626.
5Swinkels OQ, Prins M, Kucharekova M, et al. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. Br J Dermatol, 2002,146: 621-626.
6Swinkels OQ, Prins M, Tosserams EF, et al.The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.Br J Dermatol, 2001, 145: 63-69.
7Koo J, Cuffie CA, Tanner DJ, et al.Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.Clin Ther, 1998, 20: 283-291.
8Monastirli A, Georgiou S, Pasmatzi E, et al,Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis. Skin Pharmacol Appl Skin Physiol, 2002, 15: 246-251.
9Bowman PH, Maloney JE, Koo JY. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study. J Am Acad Dermatol, 2002, 46: 907-913.
10Hecker D, Worsley J, Yueh G, et al. In vitro compatibility of tazarotene with other topical treatments of psoriasis. J Am Acad Dermatol, 2000, 42: 1008-1011.
